Louis obtained his Bachelor's degree in Chemistry from the "Université D'État D'Haïti" in 2010. Subsequently, he embarked on his graduate studies journey at the University of Puerto Rico Rio Piedras, where he successfully completed his doctoral studies in chemistry in 2021, under the guidance of esteemed mentors Dr. Kai Griebenow and Dr. Arthur Tinoco. His doctoral research focused on the development of protein hybrids and conjugates of Cytochrome c with the capability to target cancer cells and nano-formulations for the targeted delivery of therapeutic proteins.
Following the completion of his Ph.D., Louis accepted the role of a postdoctoral fellow at MD Anderson Cancer Center. During his time at MD Anderson Cancer Center, his research primarily focused on investigating the mechanisms of PARP-1-mediated regulation of NET formation and exploring potential regulatory strategies. Presently, Louis holds the position of a Postdoctoral Associate in Dr. Piret's laboratory. He is actively engaged in the development of high-throughput assays aimed at screening novel small molecule therapeutics. His goal is to contribute significantly to the field of therapeutic development, capable of improving human life, and to dedicate time and effort to advancing scientific knowledge and innovation.
